RecruitingNot ApplicableNCT03382938

Dexmedetomidine Wound Infiltration in Cesarean Section

Wound Infiltration With Dexmedetomidine in Cesarean Section: Effect on Postoperative Analgesia

Sponsor

Attikon Hospital

Enrollment

100 participants

Start Date

Aug 23, 2019

Study Type

INTERVENTIONAL

Conditions

Postoperative Pain

Summary

The effects of four different wound infiltration protocols in cesarean section will be investigated on parturient' pain intensity, PCA morphine consumption given, side effects and parturient' overall satisfaction. One group will receive for wound infiltration dexmedetomidine, the second ropivacaine, the third dexmedetomidine combined with ropivacaine, while the last one will receive normal saline (placebo group).

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying 0,9% saline, a drug called Dexmedetomidine, and others for people with postoperative pain. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.